ArticleScientific reports2023

Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma.

Aurel Prosz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.